ProfileGDS5822 / ILMN_2529091
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 30% 32% 33% 9% 26% 27% 15% 7% 12% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 115.430
GSM1276600PDAC Late Ablation Control 217.932
GSM1276601PDAC Late Ablation Control 31133
GSM1276602PDAC Late Ablation 18.49
GSM1276603PDAC Late Ablation 213.826
GSM1276604PDAC Late Ablation 314.427
GSM1303940PDAC Late Ablation_anti-CTLA4 111.215
GSM1303941PDAC Late Ablation_anti-CTLA4 25.37
GSM1303942PDAC Late Ablation_anti-CTLA4 37.512